Revenue and earnings declined sharply in Q2 2024, but equity improved after a rights issue. Strategic acquisitions and new business areas position the company for recovery as market conditions show early signs of improvement.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.